The US Bankruptcy Court gave an order approving the sale of certain assets of Tricida, Inc. on February 22, 2023. The debtor has been authorized to sell its certain assets to Renibus Therapeutics, Inc. for a purchase price of $0.25 million in cash plus assumption of assumed liabilities. The debtor's assets include intellectual property assets.

At the auction held, Renibus Therapeutics, Inc. emerged as the winning bidder. Cheston J. Larson; Ted Dillman; Claire Drucker of Latham & Watkins LLP acted as legal advisors to the purchaser.